• The University of Western Australia (M519), 35 Stirling Highway,

    6009 Perth


Calculated based on number of publications stored in Pure and citations from Scopus

Personal profile


Louise Winteringham leads the Translational Cancer Research Program at the Perkins. Shas an extensive background in immunology and haematology focusing on the molecular and cellular biology of cancer, in particular haematological cancers. She completed her MSc in the Department of Clinical Immunology at Royal Perth Hospital investigating the impact of non-coding regions within the Major Histocompatibility Complex. Following three years working at St Bartholomew's Hospital in London, Louise was awarded the Richard Walter Gibbon Fellowship from the Faculty of Medicine, Dentistry and Health Sciences at UWA to undertake her PhD so she returned to Perth where she joined the Leukemia Laboratory at WAIMR, headed by Professor Peter Klinken. Louise continued her work in cancer research focusing on the biochemical and cellular mechanisms that drive oncogenesis. She has identified several novel genes associated with the development and progression of cancer. In 2017 she initiated the Translational Cancer Research Program at The Perkins, developing collaborations with pathologists and surgeons to provide a co-ordinated approach to quickly move laboratory discoveries into cancer treatments. As part of this program, she has established pre-clinical models able to accurately evaluate new cancer treatments that modulate our own immune systems to fight cancer. These models are currently being used to develop precision oncology medicine in combination with several omics technologies.

Funding overview

2018-2023 CI A Forrest, 41 AIs including L Winteringham. The CRT Collaborative Cancer Research Grant: Enabling advanced single cell cancer genomics in Western Australia. Requested AUD 6.5M.

2013–2015 Development of a Murine Cell Model of Diamond Blackfan Anaemia
Klinken, P. & Winteringham, L. Captain Courageous Foundation AUD 259,927

2013-2015 Leukemia transcriptomics. Winteringham, L., Klinlen, S.P. McCusker Foundation AUD 600,000

2015 Illumina NeoPrep Library System. Morahan, G., Winteringham, L., Forrest, A., Lister, R., Heng, J., Fox, A. National Health & Medical Research Council NHMRC AUD 39,136

2014 Targeting Acute Myeloid Leukemia with micro RNAs
LWinteringham, L., Klinken, S.P. Rachael Doherty Foundation AUD 92,000

2010-2012 Characterization of Haemopoietic Lineage Determining Genes. Klinken, P, Bond, C., Winteringham, L., National Health & Medical Research Council NHMRC AUD 608,500

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Industry keywords

  • Biotechnology
  • Health
  • Drug Discovery
  • Medicine and Pharma
  • Diagnostics

Research expertise keywords

  • Cancer
  • Novel cancer genes
  • Red blood cells
  • Cancer - translation
  • Personalised medicine
  • Humanised mice
  • Pre-clinical models
  • Leukemia


Dive into the research topics where Louise Winteringham is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or